Home
Latest
E-paper
Companies
Industry
Economy
Blueprint
Finance
Markets
Budget
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Immigration
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Indulgence
Premium
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Q3 Preview: Strong domestic sales set to lift pharma revenues by up to 11%
Strong domestic demand is set to lift pharma revenues by up to 11% in Q3FY26, though pressure from generic Revlimid in the US may limit profit growth
Gautam Adani charged by SEC: Key FCPA corruption cases and their results
US SEC accused Gautam Adani and seven others of paying $265 million in bribes to Indian government officials to secure solar energy project contracts for Adani Green Energy
Teva faces fine for disparaging rival multiple sclerosis medicine: Report
The EU competition enforcer's tough line underscores its concerns that such practices could stifle innovation in the pharmaceutical industry
US FDA nod to Teva for key specialty product to weigh on Sun Pharma
Strong US portfolio, margin gains and India business growth to support stock
Teva Pharma leases 5 floors in Mumbai complex
To pay Rs 20-cr rent for 150,000 sq ft in Goregaon; may be made India headquarters
